BIJU BALAKRISHNAN

Dr. BIJU BALAKRISHNAN

Slade Health, ICON Group
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
QYQi Yang
Qi Yang
QLQI LIANG
QI LIANG
BBBIJU BALAKRISHNAN
BIJU BALAKRISHNAN
DBDamien Belobrajdic
Damien Belobrajdic
QFQian-Jin Feng
Qian-Jin Feng
WZWei Zhang
Wei Zhang
Understanding how dietary nutrients modulate the gut microbiome is of great interest for the development of food products and eating patterns for combatting the global burden of non-communicable diseases. In this narrative review we assess scientific studies published from 2005 to 2019 that evaluated the effect of micro- and macro-nutrients on the composition of the gut microbiome using in vitro and in vivo models, and human clinical trials. The clinical evidence for micronutrients is less clear and generally lacking. However, preclinical evidence suggests that red wine- and tea-derived polyphenols and vitamin D can modulate potentially beneficial bacteria. Current research shows consistent clinical evidence that dietary fibers, including arabinoxylans, galacto-oligosaccharides, inulin, and oligofructose, promote a range of beneficial bacteria and suppress potentially detrimental species. The preclinical evidence suggests that both the quantity and type of fat modulate both beneficial and potentially detrimental microbes, as well as the Firmicutes/Bacteroides ratio in the gut. Clinical and preclinical studies suggest that the type and amount of proteins in the diet has substantial and differential effects on the gut microbiota. Further clinical investigation of the effect of micronutrients and macronutrients on the microbiome and metabolome is warranted, along with understanding how this influences host health.

1 April 2010 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
BBBIJU BALAKRISHNAN
BIJU BALAKRISHNAN
KHKimiora Henare
Kimiora Henare
ETEric B. Thorstensen
Eric B. Thorstensen
APAnna P. Ponnampalam
Anna P. Ponnampalam
MMMurray Mitchell
Murray Mitchell

26 April 2021 in Molecular Reproduction and Development
Verified
Journal Article
Open access
PDF file
SMSheryl K. Munro
Sheryl K. Munro
BBBIJU BALAKRISHNAN
BIJU BALAKRISHNAN
ALAbbey C. Lissaman
Abbey C. Lissaman
PGPalak Gujral
Palak Gujral
APAnna Ponnampalam
Anna Ponnampalam
Cytokines are important regulators of pregnancy and parturition. Aberrant expression of proinflammatory cytokines during pregnancy contributes towards preterm labor, pre‐eclampsia, and gestational diabetes mellitus. The regulation of cytokine expression in human cells is highly complex, involving interactions between environment, transcription factors, and feedback mechanisms. Recent developments in epigenetic research have made tremendous advancements in exploring histone modifications as a key epigenetic regulator of cytokine expression and the effect of their signaling molecules on various organ systems in the human body. Histone acetylation and subsequent deacetylation by histone deacetylases (HDACs) are major epigenetic regulators of protein expression in the human body. The expression of various proinflammatory cytokines, their role in normal and abnormal pregnancy, and their epigenetic regulation via HDACs will be discussed in this review.

27 July 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
BBBIJU BALAKRISHNAN
BIJU BALAKRISHNAN
QLQI LIANG
QI LIANG
KFKevin Fenix
Kevin Fenix
BTBunu Tamang
Bunu Tamang
EHEhud Hauben
Ehud Hauben
WZWei Zhang
Wei Zhang
Astragalus root (Huang Qi) and Shiitake mushrooms (Lentinus edodes) are both considered medicinal foods and are frequently used in traditional Chinese medicine due to their anticancer and immunomodulating properties. Here, the scientific literatures describing evidence for the anticancer and immunogenic properties of Shiitake and Astragalus were reviewed. Based on our experimental data, the potential to develop medicinal food with combined bioactivities was assessed using Shiitake mushrooms grown over Astragalus beds in a proprietary manufacturing process, as a novel cancer prevention approach. Notably, our data suggest that this new manufacturing process can result in transfer and increased bioavailability of Astragalus polysaccharides with therapeutic potential into edible Shiitake. Further research efforts are required to validate the therapeutic potential of this new Hengshan Astragalus Shiitake medicinal food.

1 June 2010 in Placenta
Verified
Journal Article
Closed access
BBBIJU BALAKRISHNAN
BIJU BALAKRISHNAN
ETE.B. Thorstensen
E.B. Thorstensen
APA.P. Ponnampalam
A.P. Ponnampalam
MMMurray Mitchell
Murray Mitchell

1 April 2012 in Placenta
Verified
Journal Article
Closed access
RMR.H. Mortimer
R.H. Mortimer
KLK.A. Landers
K.A. Landers
BBBIJU BALAKRISHNAN
BIJU BALAKRISHNAN
HLH. Li
H. Li
MMMurray Mitchell
Murray Mitchell
KRK. Richard
K. Richard